Upstate Active Clinical Trials
Study Title:Treatment for Patients with Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor: A Groupwide Phase III Study
What is the purpose of the study?Treatment study to find ways to get rid of the tumor cells while saving the largest amount of normal kidney tissue possible.
Upstate Institutional Review Board (IRB) Number:229453
Patient Age Group:Children
Principal Investigator:Karol H Kerr, MD
Who can I contact for more information?
Name: Beatriz Kovar